Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

72 trials

NCT07851844
Not yet recruiting
Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France
Not applicable · FR · 26 sites
Registry update: 1 Oct 2026
Fresh (updated 1 month ago)
NCT06752356
Recruiting
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 3 · US · 6 sites
Registry update: 5 Nov 2026
Fresh (updated this month)
NCT07882797
Recruiting
Multimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating Polyneuropathy
Not applicable · DE · 1 site
Registry update: 27 Oct 2026
Fresh (updated this month)
NCT07638566
Not yet recruiting
A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Phase 2/3 · - · no sites listed
Registry update: 10 Jun 2026
Fresh (updated 4 months ago)
2025-522165-30-00
Recruiting
A Phase III study to evaluate how the body processes Xembify in comparison to Gamunex-C and determine the safety and in people with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · CZ, PL, RO · 10 sites
Registry update: 14 Oct 2026
Fresh (updated this month)
NCT07696377
Not yet recruiting
An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Phase 1/2 · - · no sites listed
Registry update: 10 Jul 2026
Fresh (updated 3 months ago)
NCT07304154
Recruiting
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
Phase 1 · AU, CA, US · 10 sites
Registry update: 19 Oct 2026
Fresh (updated this month)
NCT07540221
Recruiting
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Phase 3 · CZ, PL, RO, US · 15 sites
Registry update: 9 Oct 2026
Fresh (updated this month)
NCT07526493
Recruiting
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Phase 1 · CN · 1 site
Registry update: 12 May 2026
Fresh (updated 5 months ago)
NCT07478172
Recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Not applicable · US · 1 site
Registry update: 17 Mar 2026
Ageing (updated 7 months ago)
NCT07333196
Not yet recruiting
Tongji NADs Cohort
Not applicable · CN · 1 site
Registry update: 21 Jan 2026
Ageing (updated 9 months ago)
NCT07273903
Recruiting
Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices
Not applicable · DE · 2 sites
Registry update: 10 Jun 2026
Fresh (updated 4 months ago)
NCT07337785
Recruiting
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Early phase 1 · CN · 1 site
Registry update: 12 May 2026
Fresh (updated 5 months ago)
NCT07597733
Active, not recruiting
Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Not applicable · CN · 1 site
Registry update: 19 May 2026
Fresh (updated 5 months ago)
NCT07091630
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Phase 3 · AR, AT, BG, BR, CN, CO, CZ, DK, EE, FI, FR, GB, GE, GR, HU, IL, IT, JP, KR, MD, NL, PL, RO, SG, SI, SK, US · 98 sites
Registry update: 27 Oct 2026
Fresh (updated this month)
NCT07072676
Enrolling by invitation
The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
Not applicable · DE · 1 site
Registry update: 18 Jul 2025
Stale (updated 15 months ago)
NCT07154524
Recruiting
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Not applicable · DE · 1 site
Registry update: 11 Sept 2025
Stale (updated 13 months ago)
NCT06920004
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Phase 3 · AR, AT, AU, BG, BR, CA, CH, CO, CZ, DE, DK, EE, ES, FR, GB, GR, HU, IL, IT, JP, KR, NL, NO, PL, PT, RO, RS, SE, SG, SI, SK, US · 113 sites
Registry update: 3 Nov 2026
Fresh (updated this month)
NCT07264426
Recruiting
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Not applicable · DE, US · 23 sites
Registry update: 3 Nov 2026
Fresh (updated this month)
NCT07121985
Not yet recruiting
Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
Not applicable · - · no sites listed
Registry update: 14 Aug 2025
Stale (updated 14 months ago)

Ordered by registry start date. Freshness and sponsorship never change the order.